During the past decade, Genesis Research Services conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 8 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Genesis Research Services" #1 sponsor was "Pfizer" with 5 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Biotronik, Inc." with 1 trials sponsored, "Bioventus LLC" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Research Services" #1 collaborator was "Galapagos NV" with 2 trials as a collaborator, "BIOTRONIK NRO, Inc." with 1 trials as a collaborator, "Biotronik Australia Pty Ltd." with 1 trials as a collaborator, "Clinical Network Services (CNS) Pty Ltd" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Research Services" are "Osteoarthritis, Knee" (3 trials), "Rheumatoid Arthritis" (3 trials), "Chronic Pain" (2 trials), "Psoriatic Arthritis" (2 trials) and "Chronic Leg Pain" (1 trials). Many other conditions were trialed in "Genesis Research Services" in a lesser frequency.

Most popular intervention types in "Genesis Research Services" are "Drug" (8 trials), "Biological" (7 trials), "Device" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Filgotinib" (2 trials), "Placebo to match filgotinib" (2 trials), "Adalimumab" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Research Services" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Genesis Research Services". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Genesis Research Services, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Research Services, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".